SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-23-019894
Filing Date
2023-12-19
Accepted
2023-12-19 09:03:45
Documents
16
Period of Report
2023-12-19
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K nrbo-20231219x8k.htm   iXBRL 8-K 47631
2 EX-3.1 nrbo-20231219xex3d1.htm EX-3.1 19282
3 EX-99.1 nrbo-20231219xex99d1.htm EX-99.1 15454
4 GRAPHIC nrbo-20231219x8k001.jpg GRAPHIC 14193
5 GRAPHIC nrbo-20231219xex99d1001.jpg GRAPHIC 12945
  Complete submission text file 0001558370-23-019894.txt   270597

Data Files

Seq Description Document Type Size
6 EX-101.SCH nrbo-20231219.xsd EX-101.SCH 3149
7 EX-101.LAB nrbo-20231219_lab.xml EX-101.LAB 15921
8 EX-101.PRE nrbo-20231219_pre.xml EX-101.PRE 10135
10 EXTRACTED XBRL INSTANCE DOCUMENT nrbo-20231219x8k_htm.xml XML 4931
Mailing Address 545 CONCORD AVENUE SUITE 210 CAMBRIDGE MA 02138
Business Address 545 CONCORD AVENUE SUITE 210 CAMBRIDGE MA 02138 (857) 702-9600
NeuroBo Pharmaceuticals, Inc. (Filer) CIK: 0001638287 (see all company filings)

IRS No.: 472389984 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37809 | Film No.: 231495711
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)